These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9184925

  • 1. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin.
    Noto H, Takahashi T, Makiguchi Y, Hayashi T, Hinoda Y, Imai K.
    Int Immunol; 1997 May; 9(5):791-8. PubMed ID: 9184925
    [Abstract] [Full Text] [Related]

  • 2. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.
    Takahashi T, Makiguchi Y, Hinoda Y, Kakiuchi H, Nakagawa N, Imai K, Yachi A.
    J Immunol; 1994 Sep 01; 153(5):2102-9. PubMed ID: 8051415
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site.
    Wright SE, Kilinski L, Talib S, Lowe KE, Burnside JS, Wu JY, Dolby N, Dombrowski KE, Lebkowski JS, Philip R.
    J Immunother; 2000 Jan 01; 23(1):2-10. PubMed ID: 10687132
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
    Wang B, Zhu Y, Zhang JJ, Chen Z, Liang WB, Xu ZK.
    Asian Pac J Cancer Prev; 2011 Jan 01; 12(11):2811-7. PubMed ID: 22393946
    [Abstract] [Full Text] [Related]

  • 6. Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA.
    Milazzo C, Reichardt VL, Müller MR, Grünebach F, Brossart P.
    Blood; 2003 Feb 01; 101(3):977-82. PubMed ID: 12393470
    [Abstract] [Full Text] [Related]

  • 7. Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.
    Brossart P, Heinrich KS, Stuhler G, Behnke L, Reichardt VL, Stevanovic S, Muhm A, Rammensee HG, Kanz L, Brugger W.
    Blood; 1999 Jun 15; 93(12):4309-17. PubMed ID: 10361129
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of MUC1 on transfected cell lines influences its recognition by MUC1 specific T cells.
    Magarian-Blander J, Hughey RP, Kinlough C, Poland PA, Finn OJ.
    Glycoconj J; 1996 Oct 15; 13(5):749-56. PubMed ID: 8910002
    [Abstract] [Full Text] [Related]

  • 9. Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes.
    Ciborowski P, Konitzki WM, Blander JM, Finn OJ.
    Tumour Biol; 1998 Oct 15; 19 Suppl 1():147-51. PubMed ID: 9422100
    [Abstract] [Full Text] [Related]

  • 10. Recognition of pleural mesothelioma by mucin-1(950-958)/human leukocyte antigen A*0201-specific CD8+ T-cells.
    Roulois D, Vignard V, Gueugnon F, Labarrière N, Grégoire M, Fonteneau JF.
    Eur Respir J; 2011 Nov 15; 38(5):1117-26. PubMed ID: 21540305
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
    Kawaoka T, Oka M, Takashima M, Ueno T, Yamamoto K, Yahara N, Yoshino S, Hazama S.
    Oncol Rep; 2008 Jul 15; 20(1):155-63. PubMed ID: 18575732
    [Abstract] [Full Text] [Related]

  • 13. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.
    Brossart P, Schneider A, Dill P, Schammann T, Grünebach F, Wirths S, Kanz L, Bühring HJ, Brugger W.
    Cancer Res; 2001 Sep 15; 61(18):6846-50. PubMed ID: 11559560
    [Abstract] [Full Text] [Related]

  • 14. Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes.
    Müller MR, Grünebach F, Nencioni A, Brossart P.
    J Immunol; 2003 Jun 15; 170(12):5892-6. PubMed ID: 12794115
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mucin-1-related T cell infiltration in colorectal carcinoma.
    Mulder WM, Stukart MJ, de Windt E, Wagstaff J, Scheper RJ, Bloemena E.
    Cancer Immunol Immunother; 1996 Jul 15; 42(6):351-6. PubMed ID: 8830738
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.
    Carmon L, El-Shami KM, Paz A, Pascolo S, Tzehoval E, Tirosh B, Koren R, Feldman M, Fridkin M, Lemonnier FA, Eisenbach L.
    Int J Cancer; 2000 Feb 01; 85(3):391-7. PubMed ID: 10652432
    [Abstract] [Full Text] [Related]

  • 19. An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer.
    Wang K, Zhou Q, Guo AL, Xu CR, An SJ, Wu YL.
    Immunol Invest; 2009 Feb 01; 38(7):665-80. PubMed ID: 19811429
    [Abstract] [Full Text] [Related]

  • 20. MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells.
    Wright SE, Rewers-Felkins KA, Quinlin IS, Fogler WE, Phillips CA, Townsend M, Robinson W, Philip R.
    Immunol Invest; 2008 Feb 01; 37(3):215-25. PubMed ID: 18389441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.